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Background: Physician’s prescribing preference is increasingly used 
as an instrumental variable in studies of therapeutic effects. However, 
differences in prescribing patterns among physicians may reflect dif-
ferences in preferences or in case-mix. Furthermore, there is debate 
regarding the possible assumptions for point estimation using physi-
cian’s preference as an instrument.
Methods: a survey was sent to general practitioners (gPs) in the 
netherlands, the United Kingdom, new Zealand, ireland, Switzer-
land, and germany, asking whether they would prescribe levothy-
roxine to eight fictitious patients with subclinical hypothyroidism. 
We investigated (1) whether variation in physician’s preference was 
observable and to what extent it was explained by characteristics of 
gPs and their patient populations and (2) whether the data were com-
patible with deterministic and stochastic monotonicity assumptions.
Results: levothyroxine prescriptions varied substantially among the 526 
responding gPs. Between-gP variance in levothyroxine prescriptions 
(logit scale) was 9.9 (95% confidence interval: 8.0, 12) in the initial mixed 
effects logistic model, 8.3 (6.7, 10) after adding a fixed effect for country 
and 8.2 (6.6, 10) after adding gP characteristics. the occurring prescrip-
tion patterns falsified the deterministic monotonicity assumption. all 
cases in all countries were more likely to receive levothyroxine if a differ-
ent case of the same gP received levothyroxine, which is compatible with 
the stochastic monotonicity assumption. the data were incompatible with 
this assumption for a different definition of the instrument.
Conclusions: Our study supports the existence of physician’s prefer-
ence as a determinant in treatment decisions. Deterministic monoto-
nicity will generally not be plausible for physician’s preference as an 
instrument. Depending on the definition of the instrument, stochastic 
monotonicity may be plausible.
(Epidemiology 2016;27: 276–283)
Instrumental variable (iV) analysis is increasingly used in observational studies of therapeutic effects, with the aim 
of circumventing confounding by indication. this method 
requires a variable (the instrument) that meets the following 
conditions: (1) is associated with treatment, (2) does not affect 
the outcome other than through treatment (exclusion restric-
tion), and (3) does not share a common cause with the out-
come (independence assumption).1,2 One such instrument is 
physician’s prescribing preference, which exploits the notion 
that prescribing by a medical doctor is influenced not only by 
prognostic characteristics of the patient but also by a general 
preference of the doctor for some type of therapy when differ-
ent treatment options are available.
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Because underlying preference cannot be observed, 
physician’s preference-based iV studies use an estimate of 
physician’s preference based on prescribing behavior. the 
question remains, however, whether differences in prescrib-
ing behaviour between physicians truly reflect differences in 
preference rather than just differences in their patient popula-
tions. Furthermore, the three main iV conditions described 
above are only sufficient for the estimation of bounds of a 
treatment effect.3 to obtain a point estimate, an additional 
(fourth) assumption is required. the assumption of no het-
erogeneity of treatment effects, under which the average 
treatment effect in the population can be estimated, is often 
implausible.3 a frequently used alternative is the monoto-
nicity assumption, first described by imbens and angrist.4 
according to the original (deterministic) monotonicity 
assumption, the instrument may only be related to treatment 
monotonically in one direction for all subjects.2,4–7 a less 
strict, stochastic version of the monotonicity assumption has 
been proposed, as we will explain later.5–7
the notion that physician’s underlying prescribing 
preference affects prescribing behavior cannot be proven in 
iV study data (at the most, the assumption that physician’s 
estimated prescribing preference is unrelated to characteris-
tics of the physician’s patient population can be explored to 
some extent). Furthermore, the deterministic monotonicity 
assumption is generally not verifiable within iV study data 
and the validity of the stochastic monotonicity assumption 
can only be explored to some extent. Swanson et al.2 recently 
proposed using a study design in the form of a survey, ask-
ing physicians what their treatment decision would be for 
the same set of cases, to assess the monotonicity assumption 
empirically. Here, we perform such a study, using data from 
a survey originally performed with the aim of establishing 
differences in treatment strategies of general practitioners 
(gPs) for subclinical hypothyroidism by country and by 
patient characteristics.8 these data were therefore not pri-
marily intended for our current study, but can nevertheless 
provide a valuable insight into the plausibility of the differ-
ent monotonicity assumptions. Our aims are twofold, (1) to 
establish whether variation in physician’s preference regard-
ing treatment of subclinical hypothyroidism is observable 
when gPs are presented with the same set of patients and to 
what extent this variation is explained by characteristics of 
the gPs and (2) to establish to what extent the data are com-
patible with the deterministic and stochastic monotonicity 
assumptions.
METHODS
Study Data
the survey procedures have been described in detail 
elsewhere.8 an online survey was e-mailed to 2,710 gPs in 
the netherlands, germany, england, ireland, Switzerland, 
and new Zealand. it contained eight fictitious cases of women 
with subclinical hypothyroidism. all cases had a normal BMi, 
nonspecific complaints resulting in fatigue and a normal free 
thyroxine level. cases varied in age (70 years/85 years), vital-
ity status (vita/vulnerable), and thyroid stimulating hormone 
(tSH; 6 mU/l/15 mU/l; table 1). For each case, gPs were 
asked if they would start treatment, and, if so, what levothy-
roxine starting dose they would choose. For the purposes of 
this study, we only consider the responses on whether treat-
ment would be started. Furthermore, gPs were asked ques-
tions about their gender, years of experience as a gP, the 
percentage of elderly patients registered in their practice, the 
time since the last diagnosis of subclinical hypothyroidism 
and the time since last starting levothyroxine treatment in a 
patient with subclinical hypothyroidism. For the full survey, 
we refer to appendix 2 of Den elzen et al.,8 which reports the 
study for which the survey was originally performed. the sur-
vey study was exempt from ethical review in the netherlands, 
germany, england, Switzerland, and new Zealand, as it dis-
cussed only fictional patients. in ireland, the clinical research 
ethics committee of the cork teaching Hospital approved the 
survey.8
Possible Assumptions for Point Estimation
Deterministic Monotonicity
For a dichotomous instrument, the deterministic mono-
tonicity assumption is usually defined as the absence of 
“defiers.”1,2,6,9 the iV analysis then estimates a local aver-
age treatment effect among the “compliers.”1,4 these “com-
pliers” or “marginal patients” are those patients who would 
receive treatment at the “encouraging” value of the instru-
ment (e.g., preference for treatment), but not at the “nonen-
couraging” value of the instrument (e.g., preference for no 
treatment).1,5,9,10 as discussed by Swanson et al.2 and Small 
et al.,6 for physician’s preference as an iV, the compliance 
class (whether the patient is a complier, defier, always taker or 
never taker) is generally not well defined.
Hernán and robins3 have formulated the determinis-
tic monotonicity assumption for physician’s preference as a 
continuous instrument. this would translate to the example of 
subclinical hypothyroidism as follows: if physician a would 
TABLE 1. Age, Vitality Status, and TSH of the Eight Cases in 
the Survey
Case Age Vitality Status TSH (mU/L)
1 70 Vital 6
2 70 Vulnerable 6
3 70 Vital 15
4 70 Vulnerable 15
5 85 Vital 6
6 85 Vulnerable 6
7 85 Vital 15
8 85 Vulnerable 15
adapted with permission from Br J Gen Pract. 2015;65:e121–e132.
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Boef et al. Epidemiology  •  Volume 27, Number 2, March 2016
278 | www.epidem.com © 2015 Wolters Kluwer Health, Inc. All rights reserved.
treat a certain patient with subclinical hypothyroidism with 
levothyroxine, then all physicians with a preference greater 
than or equal to the preference of physician a should treat 
that patient with levothyroxine. it is this assumption which 
we will assess for our survey data. it would correspond to 
global monotonicity as described by Swanson et al.2 (local 
monotonicity was also described by Swanson et al.2: for this 
somewhat more relaxed version of the assumption monotonic-
ity must hold for specific pairs of physicians). For continuous 
instruments, the local average treatment effect is a weighted 
average of treatment effects in multiple subgroups of patients 
(e.g., subgroups of patients who would receive levothyroxine 
from physicians with a certain preference but not from physi-
cians with a lower preference).1,3
Stochastic Monotonicity
the alternative to deterministic monotonicity pro-
posed is the stochastic monotonicity assumption, which 
states that the instrument should be related to treatment 
monotonically across subjects within strata of a sufficient 
set of measured and unmeasured common causes of treat-
ment and the outcome.6
if we view the cases in our survey not as individual 
cases but as strata of patients with the same relevant character-
istics, the stochastic monotonicity assumption requires gPs’ 
preference to be related to treatment monotonically in one 
direction across patients in each of these strata. this means 
that the probability of levothyroxine treatment for patients 
treated by gPs with preference a should be at least as high as 
for patients treated by gPs with a lower preference, within all 
strata of patients.
Under the stochastic monotonicity assumption, the 
effect estimated is a weighted average of treatment effects in 
the different strata of patients, with more weight given to those 
strata in which the instrument is strongest.5,7 Small et al.6 have 
named this the strength-of-iV weighted average treatment 
effect (SiVWate). We point out that, in their identification 
framework for the SiVWate and local average treatment 
effect, Small et al.6 formulate the three main iV assumptions 
differently to how we formulated these assumptions in our 
introduction.
Analysis
Variation in Preference for Levothyroxine and Its 
Determinants
For each gP who completed all survey questions, we 
calculated the total number of cases treated with levothyrox-
ine, as a measure of the gP’s relative preference for treatment 
with levothyroxine in subclinical hypothyroidism.
to investigate the effect of gP characteristics on their 
tendency to prescribe levothyroxine, we used mixed effects 
logistic regression. all cases completed by the gPs were 
included, with treatment with levothyroxine (no/yes) as the 
outcome. We ran the following (prespecified) models:
Model 1: a random effect for gP and fixed effects for 
characteristics of the case (age 70 or 85, tSH 6 or 15 mU/l, 
vital or vulnerable disposition).
Model 2: Model 1 plus a fixed effect for country.
Model 3: Model 2 plus a fixed effect for gP gender and 
years of experience (<5, 5–10, 11–15, 16–20, 21–25, >25 years).
Model 4: Model 3 plus a fixed effect for percent-
age of patients in the gP’s practice ages ≥65 years (<10%, 
10%–20%, 20%–30%, >30%) and time since last diagnosis 
of subclinical hypothyroidism (<1 week, 1 week–1 month, 
1 month–1 year, 1–3 years, >3 years).
the parameter of interest was the variance of the ran-
dom effect of the gP (“between-gP variance in preference”), 
which is calculated on a log odds scale. the interest lies in 
whether this variance decreases as country and characteristics 
of the gP are added to the model.
Deterministic Monotonicity Assumption
to investigate the monotonicity assumption, we made a 
matrix plot11 for each country, with cases 1 to 8 on the X axis and 
the gPs, ordered from highest to lowest preference, on the Y axis, 
the color of each cell indicating whether levothyroxine was pre-
scribed. this was used to visually examine whether the determin-
istic monotonicity assumption holds. gPs who did not complete 
the survey were not included in these plots. eFigure 1 (http://
links.lww.com/eDe/a993) shows a matrix plot with the pattern 
expected if deterministic monotonicity holds completely: physi-
cians with a certain preference always prescribe levothyroxine to 
those cases for which physicians with the same or a lower prefer-
ence prescribe levothyroxine. (From these plots, which show the 
complete data pattern, it is also possible to derive whether deter-
ministic monotonicity could hold for specific instruments such as 
treatment of the previous patient of the same gP.)
Stochastic Monotonicity Assumption
the exact formulation of the stochastic monotonic-
ity assumption depends on the definition of the instrument. 
Because Small et al. discuss the stochastic monotonicity 
assumption in the context of a binary instrument, using treat-
ment of the previous patient as an example, and because treat-
ment of the previous patient is a frequently used physician’s 
preference-based instrument, we evaluated whether stochastic 
monotonicity could hold for this instrument. Because all gPs 
were presented with all cases in the same order, we cannot 
use the true previous case as instrument. We therefore con-
sidered each other case as a potential previous patient (i.e., 
for each case there were seven potential previous patients per 
gP). We denote the potential previous patient as the “other 
patient.” each possible index patient–other patient combina-
tion was classified according to the treatment of both patients 
and summed across gPs to a total per case (per country). 
For each case, we calculated the probability of levothyroxine 
treatment if the other patient received levothyroxine and if the 
other patient did not receive levothyroxine.
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Epidemiology  •  Volume 27, Number 2, March 2016 Instrumental Variable Assumptions in Survey Data
© 2015 Wolters Kluwer Health, Inc. All rights reserved. www.epidem.com | 279
as a sensitivity analysis, we also assessed the stochastic 
monotonicity assumption for the proportion of all other cases 
the same gP decided to treat (although we note that Small 
et al.6 only discussed the stochastic monotonicity assumption 
with respect to a dichotomous instrument). We performed 
this analysis for the two countries with the largest number of 
responding gPs (the netherlands and Switzerland).
Missing Data
there was a technical problem in the electronic question-
naire sent to the Dutch gPs, resulting in 16 missing answers 
for case 6. Missing answers due to this technical problem were 
imputed, using logistic regression (10 imputations) with coun-
try, the answers for all other cases and characteristics of the 
gP as predictors.
analyses were performed using Stata 12 (Statacorp lP. 
2011, college Station, tX).
RESULTS
a total of 526 gPs from eight countries responded to 
the survey. etable 1 (http://links.lww.com/eDe/a993) lists the 
response rates per country. the overall response rate was 19% 
(526/2,710) and ranged from 4% (new Zealand) to 41% (the 
netherlands). the number of responding gPs ranged from 
21 from ireland to 262 from Switzerland. table 2 shows the 
characteristics of the gPs. Of the 526 respondents, 468 (89%) 
answered all questions and 71% were male. the years of experi-
ence ranged from <5 years (8%) to >25 years (29%). Seventy 
percent of responding gPs had ≥20% patients aged 65 years and 
over in their practice and the vast majority (91%) had diagnosed 
a patient with subclinical hypothyroidism within the last year.
Variation in Number of Levothyroxine 
Prescriptions
Figure 1 displays the distribution per country of the total 
number of cases for which the gP decided to start levothyrox-
ine. there was substantial variation in this total within each 
country. the most frequent number of levothyroxine prescrip-
tions was four for the UK, new Zealand, ireland, and Switzer-
land, zero for the netherlands, and eight for germany.
Association Between GP Characteristics and 
Treatment Preference
table 3 displays results of the mixed effects logistic 
regression used to investigate the effect of gP characteristics 
on levothyroxine prescription. country explained some of the 
variance in levothyroxine prescription between gPs, as shown 
by the reduction in between-gP variance from 9.9 (95% ci: 
8.0, 12) to 8.3 (6.7, 10) after adding a fixed effect for country. 
adding gP characteristics (model 3) resulted in a very small 
reduction in between-gP variance in treatment to 8.2 (6.6, 10). 
adding time since last subclinical hypothyroidism diagnosis 
and the proportion of patients ages 65 years and over (model 
4) resulted in a similarly small reduction. there was there-
fore still substantial variation in levothyroxine prescription 
among gPs after adjusting for all available patient and doctor 
characteristics.
Deterministic Monotonicity Assumption
Figure 2 shows matrix plots per country of the treatment 
decisions for each case by each gP. gPs are ordered from high-
est (eight cases treated) to lowest preference (0 cases treated). 
the prescription patterns of the UK (Figure 2B) only showed 
a single violation of deterministic monotonicity: the gP who 
prescribed levothyroxine to five cases treated case 2, while the 
gP who prescribed levothyroxine to six cases did not treat case 
2. there were more violations of deterministic monotonicity in 
the other countries. treating all cases with a tSH of 15 mU/l 
was a common pattern in the UK, the netherlands, new Zea-
land, Switzerland, and ireland. For example, 75 of 89 gPs who 
treated four cases in Switzerland decided to initiate levothy-
roxine in cases 3, 4, 7, and 8. in both the netherlands and 
Switzerland, most gPs with a lower preference treated (one or 
more) cases with a high tSH only and most gPs with a higher 
preference treated at least the high tSH cases. However, there 
was not a consistent pattern regarding the 5th, 6th,or 7th case 
treated, or the 1st, 2nd, or 3rd case treated within those with a 
tSH of 15 mU/l. Prescribing patterns in germany differed 
TABLE 2. Characteristics of Participating GPs
GP Characteristics
No. (%)
Total n = 526
country
  the netherlands 129 (25)
  United Kingdom 22 (4)
  new Zealand 31 (6)
  ireland 21 (4)
  Switzerland 262 (50)
  germany 61 (12)
Male 373 (71)
experience as a gP (years)
  <5 41 (8)
  5–10 70 (13)
  11–15 90 (17)
  16–20 82 (16)
  21–25 88 (17)
  >25 155 (29)
Patients ages 65 years and over in gP practice (%)
  <10 35 (7)
  10–20 122 (23)
  20–30 188 (36)
  >30 181 (34)
time since last subclinical hypothyroidism diagnosis
  <1 week 76 (14)
  1 week–1 month 194 (37)
  1 month–1 year 211 (40)
  1–3 years 27 (5)
  >3 years 18 (3)
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from those in other countries: many gPs (25 of 55) treated all 
cases with levothyroxine, and for the other gPs the prescribing 
patterns were less consistent.
Stochastic Monotonicity Assumption
table 4 displays the probability of levothyroxine pre-
scription per case, dependent on treatment of a different patient 
of the gP. the probability of levothyroxine prescription was 
higher if the other patient was prescribed levothyroxine for 
nearly all cases in all countries. exceptions were case 1 in the 
UK and in new Zealand, for whom treatment probability did not 
differ depending on the other patient’s treatment. importantly, 
there were no cases for whom the probability of levothyroxine 
was higher if the other patient did not receive levothyroxine 
(i.e., the instrument was related to treatment in the same direc-
tion for all cases in all countries). the instrument strength (the 
difference between the probability of the index patient receiv-
ing levothyroxine if the other patient received levothyroxine 
and the probability of the index patient receiving levothyroxine 
if the other patient did not receive levothyroxine) varied across 
cases within each country. For example, in the netherlands, it 
varied from 20% (case 1) to 47% (case 4).
the sensitivity analysis in which we evaluated the sto-
chastic monotonicity assumption for a continuous instrument 
(the proportion of all other cases treated) showed violations of 
this assumption (etable 2; http://links.lww.com/eDe/a993). 
although for both countries, the probability of treatment 
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FIGURE 1. Distribution per participating country of the number of cases for which a GP would prescribe levothyroxine. A, The 
Netherlands (n = 117). B, United Kingdom (n = 21). C, New Zealand (n = 25). D, Ireland (n = 15). E, Switzerland (n = 235).  
F, Germany (n = 55).
TABLE 3. Between GP Variance in Treatment
Model
Between GP Variance  
(95% CI)
1: random effect for gP; fixed effect for age, 
tSH and vitality status of case
9.9 (8.0, 12)
2: Model 1 + fixed effect for country 8.3 (6.7, 10)
3: Model 2 + fixed effect for gender and years  
of experience
8.2 (6.6, 10)
4: Model 3 + fixed effect for time since last 
diagnosis of subclinical hypothyroidism and 
proportion of patients ages 65 years and greater
8.0 (6.5, 9.9)
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increased as the value of the instrument increased for all cases, 
it did not increase monotonically. Specifically, the probability 
of treatment was higher if 3/7 other cases were treated than if 
4/7 other cases were treated.
DISCUSSION
this survey study showed marked within-country varia-
tion among gPs in their tendency to treat patients with sub-
clinical hypothyroidism with levothyroxine. Presenting the 
same cases to all gPs ensured that observed differences in pre-
scribing behavior truly reflect differences in preference, rather 
than differences in case-mix. the existence of underlying 
relative preference for levothyroxine treatment for subclinical 
hypothyroidism patients among gPs as a “pseudo-random” 
phenomenon is further supported by the very limited decrease 
in between-gP variance in levothyroxine prescription after 
adjusting for gP characteristics. even country explained a 
relatively small amount of the variation: the within-country 
variation is considerable compared with between-country 
differences.
the minimal amount of between-gP variance in levo-
thyroxine prescription explained by gP characteristics within 
countries is reassuring with regard to main iV assumptions. 
if gP gender and years of experience were related to relative 
preference for levothyroxine, this would threaten the validity 
of the exclusion restriction assumption: years of experience 
in particular may affect the prognosis of subclinical hypothy-
roidism patients through other ways than levothyroxine pre-
scription. if the proportion of older patients were related to 
preference for levothyroxine, this would threaten the validity 
of the independence assumption: the baseline prognosis of 
patients would then differ according to gP’s preference. With 
regard to the independence assumption, it is important to make 
the distinction between physician’s preference as assessed in 
this survey and physician’s preference as it is typically used 
as iV in observational studies. a measure of preference based 
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FIGURE 2. Matrix plots of the prescription patterns of the GPs within each country. GPs are ordered from highest to lowest pref-
erence, with their response for each case indicated by the color of the cell (yes: dark-grey, no: light-grey, missing: mid-grey). GPs 
with equal preferences were ordered according to their preferences for case 1 (first yes, then no) to 8, and subsequently by their 
identification-number (if all answers were equal). A, The Netherlands (n = 117). B, United Kingdom (n = 21). C, New Zealand  
(n = 25). D, Ireland (n = 15). E, Switzerland (n = 235). F, Germany (n = 55).
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on previous patients of the physician is typically used: the 
treatment of these previous patients is determined both by 
the underlying preference of the physician and by character-
istics of these patients.2 Physicians with the same underlying 
preference (i.e., who would give the same responses to our 
survey questions) can have a different case-mix of patients, 
and an estimate of their preference based on treatment of 
these patients would then differ. although the assumption 
of no confounding seems to hold for underlying preference 
in our survey data, it may well be violated in observational 
data if measures of preference based on treatment of previous 
patients are used, due to confounding by case-mix. this issue 
of confounding of instruments based on prescribing history 
was also discussed by Swanson et al.2
the preference patterns observed within the six coun-
tries deviated in varying degrees from the pattern expected if 
the deterministic monotonicity assumption would hold. the 
violation of the deterministic monotonicity assumption in this 
survey with relatively simple case descriptions indicates it is 
unlikely to hold for physician’s preference as an instrument in 
true prescription data. For a dichotomous instrument, the bias 
in the local average treatment effect estimate caused by viola-
tion of deterministic monotonicity depends on the proportions 
of compliers and defiers and the difference in treatment effects 
for compliers and defiers.9 For a multilevelled or continuous 
instrument, the bias caused by violation of the deterministic 
monotonicity assumption will be determined by analogous 
factors (i.e., the severity and pattern of the deviation from 
monotonicity) and the level of heterogeneity of treatment 
effects. in our example, heterogeneity is most likely to exist 
according to tSH levels, but looking at tSH only, there is 
relatively little violation of deterministic monotonicity.
in these data, the stochastic monotonicity assumption was 
not falsified when treatment of a different patient of the same gP 
was used as an instrument. However, in the sensitivity analysis, 
using the proportion of all other patients of the same gP treated 
as an instrument, the data were not compatible with the sto-
chastic monotonicity assumption for that instrument. this may 
be due to the specific setting of the study: a certain proportion 
of other patients treated often corresponds to a certain pattern 
of specific cases treated in these data. Overall, these results sug-
gest that the stochastic monotonicity assumption may be plau-
sible for physician’s preference-based iV studies, depending on 
how the instrument is defined. estimates of preference based on 
a larger number of previous patients may be more likely in gen-
eral to violate stochastic monotonicity, because the probability 
of treatment must increase monotonically across all levels of 
these instruments for all strata of patients.
the effect estimate under the stochastic monotonicity 
assumption is not the local average treatment effect but the 
strength-of-iV-weighted treatment effect, a generalization of 
the local average treatment effect with a similar interpreta-
tion.6 there has recently been discussion on the usefulness of 
the local average treatment effect. it centers around the ques-
tion of whether the treatment effect for the compliers is a rel-
evant effect,12,13 particularly because we cannot identify who 
the compliers are.12 the strength-of-iV-weighted treatment 
effect has similar drawbacks to the local average treatment 
effect: the interpretation is difficult, since it is a weighted 
average of effects in strata which we cannot identify and for 
which we do not know the weights.
the existing survey data used for this study provided a 
unique opportunity to investigate the assumptions underlying 
the use of physician’s preference as an iV, but also presented 
some limitations. One limitation is the low response rate, 
which may have affected our results in various ways. respond-
ing gPs may be more aware of guidelines and more alike in 
their prescription patterns (i.e., the deterministic monotonic-
ity assumption could be violated to a greater extent in the 
entire gP population). there may have been more “random” 
TABLE 4. Probability (%) of Levothyroxine Dependent on Treatment of a Different Case by the Same GP
Case
Country
The Netherlands  
(n = 117)
UK  
(n = 21)
New Zealand  
(n = 25)
Ireland  
(n = 15)
Switzerland  
(n = 235)
Germany  
(n = 55)
− + Δ − + Δ − + Δ − + Δ − + Δ − + Δ
1 7 27 21 0 0 0 4 4 0 27 47 20 17 45 28 50 89 39
2 4 27 23 4 6 2 3 14 11 11 45 34 10 41 31 19 73 54
3 44 90 46 64 100 36 82 100 18 84 100 16 67 96 30 76 97 20
4 45 92 47 64 100 36 60 83 23 84 100 16 62 93 31 68 95 27
5 4 27 22 2 8 5 5 12 6 11 45 34 7 36 29 15 64 50
6 6 26 20 2 8 5 9 25 16 22 50 28 11 38 27 23 72 49
7 39 85 46 64 100 36 63 89 26 65 90 25 61 90 29 65 93 28
8 40 78 38 59 94 35 45 74 29 70 87 17 61 90 30 46 87 41
Percentage of yes answers per case within each country, dependent on the treatment of a different case (the “other patient”) by the same gP. each other answer of the same gP 
was used as an “other patient.” treatment of the “previous patient” is indicated by − (no levothyroxine) and + (levothyroxine). the columns indicate the following (in %): −: Pr[D = 1 
|Z = 0]; +: Pr[D = 1|Z = 1]; Δ: Pr[D = 1|Z = 1] − Pr[D = 1|Z = 0].
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variation in answers if all gPs had responded (i.e., if underly-
ing preference is a stronger determinant of treatment in the 
respondents than in gPs overall). this would have reduced the 
overall strength of gP’s preference as an instrument. However, 
we would not expect it to affect the validity of the stochastic 
monotonicity assumption for treatment of one other case as 
the instrument: we do not expect such vastly different patterns 
among nonrespondents that treatment of a particular case 
would be inversely related to treatment of a different case.
all gPs were presented with the cases in the same order. 
random ordering of the cases per gP would have been prefer-
able for assessing preference in the context of an iV. it would 
have enabled us to use a true “previous case” for the evalua-
tion of the stochastic monotonicity assumption. Furthermore, 
the ordering of the cases may have had some influence on 
answers given for specific cases.
By evaluating the stochastic monotonicity assumptions 
across these eight patient types (strata) in the survey, we con-
sidered the characteristics that define these patient types, i.e., 
age, vitality status, and tSH levels, to be a sufficient set of 
measured and unmeasured common causes of treatment and 
the outcome. While this may hold for the simplified survey 
data, this is unlikely to be a sufficient set in a true patient 
population. We were therefore only able to evaluate the sto-
chastic monotonicity assumption for the simplified setting of 
the survey. related to this, the fictitious cases in the survey 
were not intended to represent any particular population of 
subclinical hypothyroidism patients for whom we may want to 
estimate the effect of levothyroxine treatment. rather, the sur-
vey was designed in such a manner that characteristics which 
were thought to be important in the treatment decision varied 
among the cases. the cases were intended to represent a well-
known clinical decision problem: whether to treat subclinical 
hypothyroidism. in this sense estimating a treatment effect for 
this group would be of potential interest, although the types of 
subclinical hypothyroidism patients represented by the cases 
are limited. For example, the cases were all women and there 
was no variation in the symptoms with which they presented.
Findings which may be of interest to clinicians are that 
we can distinguish several groups of factors which are related 
to the decision whether to treat a patient with subclinical 
hypothyroidism: characteristics of the patient, country (and its 
guidelines), and gP’s preference. in this setting of treatment 
of subclinical hypothyroidism, the lack of stringent guidelines 
leaves substantial room for gP’s preference to play a role in 
treatment decisions. While this would provide an opportu-
nity to utilize this variation in an iV study of the effect of 
treatment of subclinical hypothyroidism, the ultimate aim of 
such a study would paradoxically be to reduce this preference-
based variation through the development of evidence-based 
guidelines.
in conclusion, our study supports the existence of phy-
sician’s preference as a determinant in treatment decisions. 
little of the variation in preference was explained by charac-
teristics of the gP or their patient population, indicating that 
main iV assumptions may be plausible for physician’s treat-
ment preferences. the deterministic monotonicity assumption 
did not hold and will generally not be plausible for physician’s 
preference as an instrument. the stochastic monotonicity 
assumption may be plausible, depending on how the instru-
ment is defined.
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